We are live on ! Find out more
N

Nuveen Portfolio holdings

AUM $369B
1-Year Est. Return 31.66%
This Fund
S&P 500
This Quarter Est. Return
+16.98%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$295B
AUM Growth
+$35.4B
Cap. Flow
-$1.58B
Cap. Flow %
-0.53%
Top 10 Hldgs %
22.42%
Holding
3,425
New
145
Increased
1,798
Reduced
1,253
Closed
125

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$1B
2
AAPL icon
Apple
AAPL
+$797M
3
MRK icon
Merck
MRK
+$316M
4
AMZN icon
Amazon
AMZN
+$308M
5
MDT icon
Medtronic
MDT
+$298M

Sector Composition

Rank Sector Weight
1 Technology 24.73%
2 Healthcare 13.29%
3 Consumer Discretionary 13.23%
4 Financials 12.2%
5 Communication Services 9.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CBB
2226
DELISTED
Cincinnati Bell Inc.
CBB
$3.5M ﹤0.01%
229,315
-4,324
-2% -$65.7K
NREF
2227
NexPoint Real Estate Finance
NREF
$342M
$3.5M ﹤0.01%
211,719
-2,619
-1% -$40.9K
SRCE icon
2228
1st Source
SRCE
$2.12B
$3.48M ﹤0.01%
86,485
-13,857
-14% -$506K
SNDX icon
2229
Syndax Pharmaceuticals
SNDX
$1.82B
$3.48M ﹤0.01%
156,338
-30,303
-16% -$628K
CMRC
2230
Commerce.com Inc Series 1
CMRC
$184M
$3.46M ﹤0.01%
54,007
+21,200
+65% +$1.69M
PSTL
2231
Postal Realty Trust
PSTL
$699M
$3.45M ﹤0.01%
204,173
-15,304
-7% -$237K
ADTN icon
2232
Adtran
ADTN
$616M
$3.42M ﹤0.01%
231,905
-21,352
-8% -$271K
ANAB icon
2233
AnaptysBio
ANAB
$1.68B
$3.38M ﹤0.01%
157,324
-68,280
-30% -$1.66M
PLAB icon
2234
Photronics
PLAB
$1.93B
$3.38M ﹤0.01%
303,036
-5,353
-2% -$58.6K
TBPH icon
2235
Theravance Biopharma
TBPH
$877M
$3.38M ﹤0.01%
190,160
-19,473
-9% -$350K
WT icon
2236
WisdomTree
WT
$3.22B
$3.37M ﹤0.01%
629,264
-181,411
-22% -$781K
AXDX
2237
DELISTED
Accelerate Diagnostics
AXDX
$3.36M ﹤0.01%
44,365
+1,270
+3% +$114K
FRO icon
2238
Frontline
FRO
$8.85B
$3.36M ﹤0.01%
540,423
-11,436
-2% -$73.5K
BPFH
2239
DELISTED
Boston Private Financial Holdings, Inc.
BPFH
$3.33M ﹤0.01%
394,505
-2,645
-0.7% -$18.7K
BOOM icon
2240
DMC Global
BOOM
$157M
$3.32M ﹤0.01%
76,702
+421
+0.6% +$16.6K
VREX icon
2241
Varex Imaging
VREX
$523M
$3.31M ﹤0.01%
198,725
+12,650
+7% +$189K
VNDA icon
2242
Vanda Pharmaceuticals
VNDA
$302M
$3.31M ﹤0.01%
252,138
+590
+0.2% +$7.1K
UL icon
2243
Unilever
UL
$136B
$3.31M ﹤0.01%
48,770
-4,754
-9% -$323K
FWONA icon
2244
Liberty Media Series A
FWONA
$23.6B
$3.29M ﹤0.01%
90,521
-6,878
-7% -$240K
BPYU
2245
DELISTED
Brookfield Property REIT Inc. Class A Common Stock
BPYU
$3.28M ﹤0.01%
219,776
+6,216
+3% +$94.6K
NDLS icon
2246
Noodles & Co
NDLS
$107M
$3.28M ﹤0.01%
51,911
-13,304
-20% -$821K
VERI icon
2247
Veritone
VERI
$122M
$3.27M ﹤0.01%
114,755
+24,184
+27% +$418K
PSNL icon
2248
Personalis
PSNL
$1.51B
$3.26M ﹤0.01%
88,942
+2,159
+2% +$65.3K
ATEN icon
2249
A10 Networks
ATEN
$1.95B
$3.25M ﹤0.01%
329,818
-7,918
-2% -$62.2K
MBIO icon
2250
Mustang Bio
MBIO
$4.55M
$3.25M ﹤0.01%
1,145
+951
+490% +$2.27M

Similar funds

Nuveen's Q4 2020 Portfolio in Review

As of Q4 2020, Nuveen held 3,425 positions worth $295B, up 14% from $260B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Nuveen's Q4 2020 filing shows 145 new, 1,798 increased, 1,253 reduced and 125 closed positions. Its largest new stake was iShares Core MSCI EAFE ETF: 3,133,484 shares worth $216M. The largest sale was Walt Disney, an estimated $587M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Nuveen's largest Q4 2020 buy was iShares Core MSCI EAFE ETF: 3,133,484 shares worth $216M.
  • Nuveen added most to Microsoft in Q4 2020, an estimated $1B increase.
  • Nuveen's biggest Q4 2020 reduction was Walt Disney, cutting an estimated $587M.
  • Nuveen fully exited Alcon in Q4 2020, selling an estimated $174M.
  • Nuveen's ten largest holdings make up 22% of its $295B portfolio in Q4 2020.
  • Nuveen opened 145 new positions and closed 125 in Q4 2020.
  • Nuveen's portfolio value rose 14% quarter-over-quarter to $295B.

Based on Nuveen's 13F filing for Q4 2020, filed 16 Feb 2021.